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Currently, there is little evidence on the in situ antibacterial activity of essential oils (EO)
without alcohol. This study aimed to evaluate in situ the substantivity and antiplaque
effect on the plaque-like biofilm (PL-biofilm) of two solutions, a traditional formulation that
contains EO with alcohol (T-EO) and an alcohol-free formulation of EO (Af-EO). Eighteen
healthy adults performed a single mouthwash of: T-EO, Af-EO, and sterile water (WATER)
after wearing an individualized disk-holding splint for 2 days. The bacterial viability (BV)
and thickness of the PL-biofilm were quantified at baseline, 30 s, and 1, 3, 5, and 7 h
post-rinsing (Test 1). Subsequently, each volunteer wore the splint for 4 days, applying
two daily mouthwashes of: T-EO, Af-EO, and WATER. The BV, thickness, and covering
grade (CG) of the PL-biofilm were quantified (Test 2). Samples were analyzed by confocal
laser scanning microscopy after staining with the LIVE/DEAD® BacLightTM solution. To
conduct the computations of the BV automatically, a Matlab toolbox called Dentius
Biofilm was developed. In test 1, both EO antiseptics had a similar antibacterial effect,
reducing BV after a single rinse compared to the WATER, and keeping it below baseline
levels up to 7 h post-rinse (P < 0.001). The mean thickness of the PL-biofilm after rinsing
was not affected by any of the EO formulations and ranged from 18.58 to 20.19µm.
After 4 days, the T-EO and Af-EO solutions were significantly more effective than the
WATER, reducing the BV, thickness, and CG of the PL-biofilm (P < 0.001). Although,
both EO antiseptics presented a similar bactericidal activity, the Af-EO rinses led to more
significant reductions in the thickness and CG of the PL-biofilm than the T-EO rinses
(thickness = 7.90 vs. 9.92µm, P = 0.012; CG = 33.36 vs. 46.61%, P = 0.001). In
conclusion, both essential oils antiseptics had very high immediate antibacterial activity
and substantivity in situ on the 2-day PL-biofilm after a single mouthwash. In the 4-day
PL-biofilm, both essential oils formulations demonstrated a very good antiplaque effect in
situ, although the alcohol-free formula performed better at reducing the biofilm thickness
and covering grade.
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INTRODUCTION
The accumulation of bacterial biofilms on tooth surfaces results
in two of the most prevalent infectious diseases—caries and
periodontitis. Although prevention and control of these diseases
can be achieved by the daily mechanical removal of biofilms,
many people are either unable or unwilling to practice these
procedures as regularly or as efficiently as necessary. There is,
therefore, great interest in the possibility of using chemicals
to replace or augment, mechanical preventive, and therapeutic
procedures (Marsh and Bradshaw, 1993; ten Cate and Marsh,
1994; Newman, 1996).
The active ingredients present in the mouthwashes that are
most commonly used in the oral cavity include: chlorhexidine,
combinations of essential oils (EO), triclosan, cetylpyridinium
chloride, and various metal salts such as zinc compounds and
stannous fluoride. Of all of these, chlorhexidine mouthwashes
are considered to be the gold standard, as they have thus far
been the most effective in microbiological and clinical studies
(McDonnell and Russell, 1999; Tomás et al., 2008; von Ohle
et al., 2010). However, their well-known undesirable secondary
effects, mainly after regular use (Van Strydonck et al., 2012),
have led to the scientific community exploring the existence
of effective alternatives, especially when continuous daily use is
required. Accordingly, EO have been found to be as effective
as chlorhexidine at controlling gingival inflammation after 6
months of use, although the latter performs better at reducing
plaque levels (Van Leeuwen et al., 2011; Neely, 2012).
EO are composed of a wide variety of products. As a
consequence, their antimicrobial activity is related to their
composition, configuration, amount, and possible interactions
(Lis-Balchin et al., 1998). The traditional formulation containing
EO (T-EO) (Listerine R© MentolTM, Johnson & Johnson)1
are a complex mix of phenolic compounds combined with
various EO: 0.092% eucalyptol, 0.064% thymol, 0.06% methyl-
salicylate, and 0.042% menthol. All of these are included in
a hydroalcoholic vehicle containing between 21.6 and 26.9%
alcohol (Fine, 1988). As a result, T-EO contains ethanol, which
is a chemical compound used to dissolve and stabilize the
numerous substances present in the rinse. The concentration
of ethanol present in the T-EO rinses is more than 20%. Such
amounts have been found to be sufficient to dissolve the EO,
but insufficient when it comes to having a direct antibacterial
effect (Sissons et al., 1996; Marchetti et al., 2009). In fact, the
manufacturer presents the alcohol contained in the rinse (21.6%)
as being, inter alia, an inactive ingredient in its formula. Over the
years, the use of ethanol in mouthwashes, as well as their effects
on the surfaces of composite restorations (Penugonda et al., 1994)
and their possible role in the development of oropharyngeal
cancer, have been discussed (Smigel, 1991; Llewelyn, 1994).
A direct cause-and-effect correlation between the development
1Listerine Cool Mint Composition. Available online at: https://www.listerine.com/
mouthwash/antiseptic/listerine-cool-mint-mouthwash (Accessed on September
14, 2017). Listerine Cool Mint Zero alcohol composition. Available online at:
https://www.listerine.com/products/listerine-zero/listerine-cool-mint-zero-
alcohol#product-overview (Accessed on November 1, 2017).
of oropharyngeal carcinoma and the use of alcohol-containing
rinses has not been demonstrated (Moazzez et al., 2011; Bagán
et al., 2012; Gandini et al., 2012), and probably never will
be (at least by epidemiological studies; Lachenmeier, 2012).
However, it is considered desirable to eliminate ethanol from
daily mouthwashes, especially for pediatric populations and
patients at higher risk for oral cancer (McCullough and Farah,
2008; La Vecchia, 2009). Furthermore, the fact that the alcohol
is present has meant that some clinical practitioners do not
prescribe the T-EO due to this controversy (Vlachojannis et al.,
2013). All of this has led to the development of a new alcohol-
free formulation of EO (Af-EO) (Listerine R© ZeroTM, Johnson &
Johnson)1.
The composition of Af-EO is the same regarding their active
ingredients (eucalyptol, thymol, methyl salicylate, and menthol),
but sodium fluoride has been added to the mixture. Some
differences are found in their inactive ingredients. These are
based on the alcohol contained in the T-EO solution, which is
not present in the Af-EO rinse, and the presence of propylene
glycol, sodium lauryl sulfate and sucralose in the Af-EO solution,
but not the T-EO rinse.
Two different concepts should be taken into account to
measure the efficacy of antiseptics against dental plaque: the
substantivity and the antiplaque effect. The substantivity of an
oral antiseptic is defined as the prolonged adherence to oral
surfaces (teeth and mucosa) and its slow release at effective
doses which guarantee the continuation of the antimicrobial
activity (Manau Navarro and Guasch Serra, 2003). The more
substantivity an oral antiseptic has, the better. To study this in
situ, the most popular models are those that analyze the effect
that a single mouthwash has on a biofilm of more than 24 h
(García-Caballero et al., 2013; Quintas et al., 2015b).
The second concept that should be studied, the antiplaque
effect, is defined as the capacity that an agent has to prevent
the formation of bacterial aggregates (plaque) on oral surfaces.
To study this in situ effect, models start from a baseline sample
with levels of plaque near to zero in order to assess the power
of the antiseptic when it comes to reducing the formation
of bacterial plaque (normally dental plaque) compared to the
control. A 6-month clinical study using a determinate antiplaque
agent is necessary to tag an antiseptic as effective (Council on
Dental Therapeutics, 1986). However, in the literature, there is
an established model of 4 days of plaque regrowth with which
authors can assess the inhibitory activity that different agents
have; furthermore, this determines the relative efficacy of the
different formulations as being predictive of the antiplaque effect
of an antiseptic (Singh et al., 2013; Quintas et al., 2015a).
In addition, another important methodological aspect in the
in situ study of an oral antiseptic is the need to conserve the oral
biofilm intact at all stages, namely the formation, collection and
analysis of the oral samples. The goal is to not interfere with the
delicate three-dimensional structure of the oral biofilm, which
has been proved to be essential in terms of the resistance to
the effects of an antimicrobial agent (Wood et al., 2000; Beyth
et al., 2010). For these reasons, the use of intraoral disks held
in specially designed apparatus for biofilm formation combined
with the application of confocal laser scanning microscopy has
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proved to be extremely valuable when it comes to analyzing the
oral biofilm in its intact, hydrated natural state (Dong et al., 2010;
Gosau et al., 2010; Gu et al., 2012; García-Caballero et al., 2013;
Quintas et al., 2015a,b).
As Af-EO solution has come to the market, it seems
appropriate to compare their antibacterial effects to those of
traditional mouthwashes. Although, there are some studies
evaluating these effects of T-EO and Af-EO (Marchetti et al.,
2009, 2011, 2017a,b; Charles et al., 2012; Pizzo et al., 2013; Ulkur
et al., 2013), none of them have assessed and compared their
substantivity and antiplaque impact in an in situmodel of a non-
destructured oral biofilm (PL-biofilm). For this reason, the aim of
the present study was to compare the in situ antibacterial activity
(immediate effect, substantivity and antiplaque effect) of EO with
and without alcohol on the PL-biofilm.
MATERIALS AND METHODS
This research is a randomized, double-blind, crossover study
of the antibacterial and antiplaque efficacy of two available EO
solutions: a traditional formula of EOwith alcohol (T-EO) and an
alcohol-free formula of EO (Af-EO). The supporting CONSORT
checklist is available as supporting information (Supplementary
Table 1). The study received the approval of the Clinical Research
Ethics Committee of Galicia (number 2014/008) and was
registered at clinicaltrials.gov with the number NCT03146390.
URL: https://clinicaltrials.gov/ct2/show/NCT03146390.
The “a priori” sample size calculation was performed using
the program G∗Power 3.1.5 (Faul et al., 2007). The following
statistical criteria were established: (1) an effect size of 0.7; (2)
an alpha error of 0.05; and (3) a statistical power of 80%. A
sample size of 19 subjects was required by these criteria and
the application of the Wilcoxon signed-rank test to analyze the
differences in the microscopic parameters between two rinsing
protocols.
The participants were selected among dental students
at the School of Medicine and Dentistry of Santiago de
Compostela (Universidade de Santiago de Compostela, Spain),
where volunteer enrollment was sought by inviting responses
to advertisements displayed in the faculty hall asking for
participation in a research study. All these volunteers were
assessed by the same trained clinician to ensure that they
fulfilled all the inclusion and exclusion criteria that were applied
in our group’s previous publications (García-Caballero et al.,
2013; Prada-López et al., 2015a,b; Quintas et al., 2015a,b). The
inclusion criteria were the following: systemically healthy adult
volunteers aged between 20 and 45 with a good oral health
status, namely a minimum of 24 permanent teeth with no
evidence of gingivitis or periodontitis (Community Periodontal
Index score = 0; World Health Organization, 2013) and an
absence of untreated caries at the start of the study. The
following exclusion criteria were applied: smoker or former
smoker, the presence of dental prostheses or orthodontic devices,
antibiotic treatment, or routine use of oral antiseptics in the
previous 3 months, and the presence of any systemic disease
that could alter the production or composition of saliva. Before
the start of each test or experiment, a full mouth scaling with
ultrasonic instruments and teeth polishing with a rubber cup after
dental disclosure were performed by the same trained clinician
on all the selected participants (Figure 1). Written informed
consent was obtained from all the volunteers. To achieve the
aims of the study, all the participants performed two different
tests.
To test the antibacterial activity of the two EO solutions, an
in situ model of PL-biofilm growth was used. An individualized
thermoplastic splint called intraoral disk-holding splint (IDODS)
(García-Caballero et al., 2013; Prada-López et al., 2013, 2015a,b,c,
2016; Quintas et al., 2015a,b) with a capacity to hold a total of six
glass disks was made for each of the volunteers.
Test 1 (Substantivity)
The first experiment consisted of evaluating the immediate
antibacterial effect and substantivity of the T-EO and Af-EO
solutions. The volunteers wore an IDODS for 48 h to enable
growth of the PL-biofilm. They were allowed to remove it from
the oral cavity only during meals and to perform oral hygiene
measures (when it had to be stored in a provided opaque
container in humid conditions). In order to not disturb the
formation of the PL-biofilm, the volunteers could not use any
toothpaste or mouthwash as a complement to the mechanical
removal of bacterial plaque.
After 48 h, the glass disks were withdrawn one by one from
the splint from each volunteer (from right to left in a distal-
mesial direction) at baseline, 30 s, and 1, 3, 5, 7 h after performing
the different mouthwashes. These mouthwashes were practiced
under the investigator’s supervision with the IDODS present in
the oral cavity, and they were:
1A) A single, 30-s mouthwash with 20mL of sterile water
(negative control) (M-WATER).
-OR
1B) A single, 30-s mouthwash with 20mL of a traditional
EO formulation (Listerine R© MentolTM, Listerine R©, Johnson &
Johnson, Madrid, Spain) (M-T-EO).
-OR
1C) A single, 30-s mouthwash with 20mL of an alcohol-
free EO solution (Listerine R© ZEROTM, Listerine R©, Johnson &
Johnson, Madrid, Spain) (M-Af-EO).
On the day of the experiment, the volunteers were not allowed
to eat or drink during the tests. Collection of the different
PL-biofilm samples started at 11:50 a.m. (baseline sample) and
finished at 7:00 p.m. (the final sample was obtained 7 h after using
the mouthwash).
Using an internet-based, balanced randomization system
(Dallal)2, which indicated the mouthwash that each subject
should use first, second and third, all the volunteers used the
three mouthwashes, with a rest period of 2 weeks between each
application (Figure 1).
Test 2 (Antiplaque Effect)
The second experiment consisted of evaluating the antiplaque
effect of both EO formulas. During 96 h, each volunteer wore
the splints with the glass disks, withdrawing them from their
oral cavity only during meals (they were stored in an opaque
2Available online at: www.randomization.com (Accessed on September 03, 2017).
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FIGURE 1 | Protocol of the study.
container in humid conditions) and to perform oral hygiene
procedures involving only the mechanical removal of bacterial
plaque with water, without the use of any toothpaste or
mouthwash.
Using the permitted mechanical oral hygiene measures
(without the IDODS), the volunteers performed the different
protocols based on the manufacturers’ instructions (with the
IDODS in the oral cavity) over 4 days in the morning (8.30)
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after breakfast and at night (22.00) after dinner. These protocols
were:
2A) A 30-s mouthwash with 20mL of sterile water (negative
control) (4D-WATER).
-OR
2B) A 30-s mouthwash with 20mL of a traditional EO
formulation (Listerine R© MentolTM, Listerine R©, Johnson &
Johnson, Madrid, Spain) (4D-T-EO).
-OR
2C) A 30-s mouthwash with 20mL of an alcohol-free
EO solution (Listerine R© ZEROTM, Listerine R©, Johnson &
Johnson, Madrid, Spain) (4D-Af-EO).
The collection of the samples was carried out individually at
8 a.m. in the morning so that those of each volunteer were
analyzed on different days. It was determined that a minimum
of 10 h should have elapsed since the last use of the mouthwash
the previous night.
In this test, mouthwashes carried out by the volunteers were
not supervised, but they were instructed to use a measured
volume of the allocated solution. To assess the subject’s
compliance with the rinsing protocol, the bottles containing the
rinse were weighed before they were given to the volunteers. After
the 4-day period, they were asked to bring the bottles back with
the remaining mouthwash, and these were weighed again.
Using an internet-based, balanced randomization system
(Dallal), which indicated the rising protocol that each subject
should use first, second and third, all the volunteers used the
three regimes, with a rest period of 2 weeks between each protocol
(Figure 1).
Processing of the Samples of the
PL-Biofilm
As the glass disks were removed from the splint, they were
immediately immersed in 100 µL of a fluorescence solution
of LIVE/DEAD R© BacLightTM and kept in a dark chamber
at room temperature for 15min. Microscope observations
were performed by a single investigator who was unaware
of the study design using a Leica TCS SP2 laser scanning
spectral confocal microscope (Leica Microsystems Heidelberg
GmbH, Mannheim, Germany) with an HCX APOL 63x/0.9
water-immersion lens.
Four fields considered to be representative of the entirety of
the samples were selected by an observer who was blind to the
study’s conditions. Fluorescence emission was determined in a
series of XY images in which each image corresponded to each
of the Z positions (depth). The optical sections were scanned
in 1µm sections from the surface of the biofilm to its base,
measuring the maximum thickness of the field and subsequently
the mean thickness of the biofilm of the corresponding sample.
The maximum biofilm thickness of each field was divided into
three zones or equivalent layers: the outer layer (layer 1), the
middle layer (layer 2), and the inner layer (layer 3).
The capture of the data was done with the same settings in
all cases. The spatial scan mode (XYZ) and the 1,024 × 1,024
pixels scan format resolution were used. The Argon-ion and
DPSS laser were used at a 13 and 78% of maximum intensity,
respectively. The values for the pinhole, zoom and scan speed
were 121.58 microns, 1 and 400Hz, respectively. The only values
that were different depending on the sample were the offset
(range between −1 and 1%) and PMT gain which was different
for channel red and green, being in general terms, higher for
green than for red (test and positive control), due to the fact that
there was more presence of red than green signal, being for the
negative control the opposite. These values were always adjusted
to get a good quality capture without background noise, avoiding
excessive saturation of the brightest pixels of the image. As the
technician was blinded to the experiment, they were advised to
make the adjustments always consistent with what was seeing by
the objective of the microscope, obtaining an image which was
the closest as possible to reality.
The quantification of bacterial viability (BV) in the series of
XY images was determined using a cytofluorographic analysis
(Leica confocal software). In this analysis, the images of each
fluorochrome were defined as “channels” (SYTO 9 occupies
the green channel and Propidium Iodide the red channel). To
conduct the computations automatically, a Matlab toolbox called
Dentius Biofilm was developed. The main program reads all the
images from an experiment, organized in a folder tree, with the
image folder at the top, the experiment folder below this and
all the patient folders at the bottom. The program automatically
computes the number of disks, fields and 1µm sections from the
images stored in each patient’s folder.
The program considers the parameters fixed by experts: the
BV is characterized by a high value in the green channel (over
100, with a range between 0 and 255) and a low value in the
red channel (below 100). Bacteria are considered not to be viable
if the values are high in the red channel (over 100) and low
in the green channel (below 100). Values that are high in both
channels (over 100) are visually orange and are considered non-
viable bacteria. The program counts the number of pixels under
these conditions to compute the BV percentage for each 1µm
section (viable bacteria/viable bacteria + non-viable bacteria ×
100). Determination of the mean BV percentage in each field
required sections with a minimum biofilm area of 250 µm2
(∼4,750 pixels).
The program also considers the case where epithelial nuclei
are present. These are characterized by compact red areas with a
size that is greater than the bacteria, and these red points must
not be counted as non-viable bacterial population. To eliminate
these pixels, the program disregards epithelial cells, which are
characterized by: having a high value in the red channel, an
area >200 pixels, compact regions with a solidity >0.7, and a
minimum value of the mean intensity of 180. These parameters
were fixed using a training set. With this methodology, there
could be some misdetections, but the effect on the BV was very
low, as what was important was the elimination of large areas
with a high intensity.
All the results obtained for each section, field and
disk from each patient were stored in a worksheet to be
analyzed by the researchers. The BV percentage was also
stored before and after eliminating the epithelial nuclei
and their properties to localize them over the image.
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The mean BV percentage of the biofilm was calculated
for the corresponding sample and for each biofilm
layer.
In Test 2, apart from the thickness and BV, the covering grade
(CG) was also assessed. This parameter is the percentage of the
surface substrate covered by the biofilm. The cytofluorogram
itself was used for this purpose. From the maximum projection
(superposition of all captured planes) of each of the analyzed
fields, the CG percentage was obtained by calculating the sum
of the bacterial mass (viable and non-viable) with regard to
the total surface of the field (% positive within the total
area).
Statistical Analysis
The statistical analyses were performed using the R
software (R Core Team, 2016). The Shapiro–Wilk
test was performed to analyze the distribution of
the quantitative variables associated with the PL-
biofilm (thickness, BV and CG), showing mostly these
microscopic parameters a non-normal distribution in both
tests.
In Test 1 (substantivity) and Test 2 (antiplaque effect),
the Friedman test was used for intra-mouthwash and inter-
mouthwash comparisons using all the PL-biofilm samples
(including differentiating between the three biofilm layers). In
both tests, the Wilcoxon signed-rank test was used for pairwise
comparisons (with Bonferroni adjustment) of the intra- and
inter-mouthwash results (including differentiating between the
three biofilm layers). The significance level established was a
P < 0.05. In the Test 1, the Bonferroni-corrected P-values applied
were <0.003 and <0.016, and in the Test 2, this value was
<0.016.
RESULTS
A total of 30 volunteers were evaluated to obtain the calculated
sample size (n = 19). When this number of participants meeting
the inclusion and exclusion criteria was achieved, the enrollment
process was ended. A total of 11 subjects were ineligible as they
did not meet all of the inclusion criteria. All the participants
performed both of the tests, although a subject was excluded after
performing the Test 1 for an unexpected event (Supplementary
Table 2, CONSORT flow diagram). No adverse effects were
reported by them at any stage of the experiment. Eighteen
subjects completed the rinsing protocols satisfactorily in both
tests. In Test 2, the returns of each product suggested good
compliance with the instructions.
Test 1 (Substantivity)
Influence of a Single Mouthwash of T-EO and Af-EO
on the Thickness of the PL-Biofilm
Neither the T-EO nor the Af-EO antiseptics could reduce the
thickness of the PL-biofilm of 48 h after a single application.
Their baseline thicknesses were 21.81 ± 5.28µm and 20.71 ±
4.13µm, respectively. After a single mouthwash, the thicknesses
were slightly reduced (20.19 ± 3.62µm and 18.58 ± 3.14µm,
respectively), but did not achieve statistical significance.
Influence of a Single Mouthwash of T-EO and Af-EO
on the Bacterial Viability of the PL-Biofilm
The mean BV at baseline ranged between 63.99 ± 19.7%
and 79.54 ± 5.31% for all the three rising protocols, with
no statistical differences between them. Both EO formulations
achieved similar results at all the time pointsmeasured. In fact, no
differences were found between them from the immediate sample
(30 s) to the 7-h sample (Figure 2). The EO formulations were
FIGURE 2 | Percentages of bacterial viability of the PL-biofilm in baseline conditions, at 30 s, 1, 3, 5, and 7 h after a single mouthwash with sterile water (M-WATER),
with essential oils with alcohol (M-T-EO), and with essential oils without alcohol (M-Af-EO). *Statistically significant differences in regard to the 30-s sample (P < 0.003).
+Statistically significant differences in regard to the baseline (P < 0.003).
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effective at reducing the BV after a single mouthwash with respect
to their respective baseline levels (BV at 30 s for M-T-EO and
M-Af-EO = 6.53 ± 7.60% and 4.13 ± 3.89%, respectively; P <
0.001). These results were statistically lower than those from the
M-WATER (62.39± 8.17%; P < 0.001). Both solutions were able
to keep the BV under baseline levels for 7 h (BV at 7 h forM-T-EO
andM-Af-EO= 18.20± 9.38% and 20.10± 10.27%, respectively;
P < 0.001). Again, these findings were statistically lower than
those from theM-WATER (BV at 7 h= 76.78± 4.40%; P< 0.001;
Figures 2, 3).
In terms of BV recovery concerning the 30-s sample,
significant recovery was not achieved until 7 h after the use of an
M-T-EO rinse (BV at 30 s vs. at 7 h for M-EO= 6.53± 7.60% vs.
18.20 ± 9.38%; P < 0.001). However, for the M-Af-EO solution,
FIGURE 3 | Representative images of the obtained bacterial viabilities at 30 s, 3 and 7 h after a single mouthwash with sterile water (M-WATER), traditional essential
oils (M-T-EO), and alcohol-free essential oils (M-Af-EO).
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significant recovery was identified in the 3-h sample (BV at 30 s
vs. at 3 h for M-Af-EO = 4.13 ± 3.89% vs. 12.35 ± 8.86%; P <
0.001; Figure 2).
When it comes to differentiating between the three biofilm
layers, the two EO antiseptics had lower BV levels in all the layers
(Table 1). No significant differences were found in BV for the
same biofilm layer between the EO formulations, with the outer
layers being generally more viable than the inner ones in all the
samples. There were no significant differences between the three
layers for the M-T-EO rinse (BV at 30 s by layers= 6.67± 6.80%
vs. 5.63 ± 8.15% vs. 7.29 ± 9.17%, respectively; P > 0.016) or
between the deeper layers for the M-Af-EO rinse (BV at 30 s by
layers 2 and 3= 3.22± 3.24% vs. 3.51± 4.94%, respectively; P >
0.016; Table 1).
Test 2 (Antiplaque Effect)
Influence of a 4-Day Protocol of T-EO and Af-EO
Mouthwashes on the Thickness and Covering Grade
of the PL-Biofilm
The Af-EO rinses were more effective than the T-EO formulation
at reducing the thickness of the oral biofilm after 4 days of use
(thickness for 4D-T-EO vs. 4D-Af-EO= 9.92± 2.87µm vs. 7.90
± 2.91µm; P = 0.012), but both solutions were more powerful
than the negative control (thickness for 4D-WATER = 22.76 ±
6.21µm; P < 0.001; Table 2 and Figure 4).
The Af-EO rinses were more effective than the T-EO solution
at reducing the CG of the oral biofilm after 4 days of use (CG for
4D-T-EO vs. 4D-Af-EO = 46.61 ± 19.12% vs. 33.36 ± 12.01%,
respectively; P = 0.001). The two EO solutions were significantly
more effective than the negative control at reducing the CG
(CG for 4D-WATER = 73.92 ± 17.49%; P < 0.001; Table 2 and
Figure 5).
Influence of a 4-Day Protocol of T-EO and Af-EO
Mouthwashes on the Bacterial Viability of the
PL-Biofilm
The T-EO and Af-EO formulations after 4 days of use showed
similar effectiveness in maintaining the BV at significantly lower
levels than the negative control (BV for 4D-T-EO and 4D-Af-EO
vs. 4D-WATER = 26.27 ± 14.61% and 31.08 ± 16.52% vs. 51.35
± 5.38%, respectively; P < 0.001; Table 2). In terms of the BV by
layers, the outer layers had significantly more BV than the inner
ones in all the experiments. The T-EO and Af-EO formulations
were significantly more effective at reducing the BV of layers 1
and 2 than the negative control, with layer 3 unaltered (BV for
layer 1= 40.10± 17.31% and 39.81± 19.09% vs. 82.47± 7.58%,
respectively; BV for layer 2= 24.32± 16.16% and 30.73± 17.06%




This is the first study to compare the antibacterial activity in vivo
that T-EO and Af-EO solutions have on the non-destructured
oral biofilm. From a methodological perspective, to perform all
the BV computations automatically through a Matlab toolbox
called Dentius Biofilm ensures that the experiment’s findings are
accurate, quick to obtain, reliable, and repeatable, which is very
important when it comes to comparing results and extracting
robust conclusions. In the substantivity study (test 1), mean BV
data of each subject were obtained from analyzing∼160 sections
of 1µm (around 40 sections per field X four fields X one disk) for
each evaluated moment (six-time moments: baseline, 30 s, 1, 3,
5, and 7 h). In the antiplaque study (test 2), when the negative
control was applied, the mean BV values of each subject were
obtained from evaluating ∼1,200 sections (around 50 sections
per field X four fields X six disks); when antiseptic solutions were
used, the mean BV results of each subject were derived from the
analysis of ∼360 sections (around 15 sections per field X four
fields X six disks).
In the present series, the BV was assessed by the Live/Dead R©
BacLightTM fluorescence assay. This solution stains the bacteria
in red or green depending on the permeability of their
membrane (propidium iodide which stains the cell in red only
if the membrane permeability is altered). Given that the tested
antiseptics act mostly at this cellular element, this viability
method may be suitable for this type of study. Although, firstly
conceived as a technique only valid for BV assessment of single
species model (Invitrogen communication), its simplicity and
good results also in in situ studies containing multiple bacterial
species (Boulos et al., 1999; Ihalin et al., 2003; Tomás et al., 2009;
Beyth et al., 2010; Dong et al., 2010; Gosau et al., 2010; García-
Caballero et al., 2013; Tawakoli et al., 2013; Prada-López et al.,
2015a,b; Quintas et al., 2015a,b) has produced the manufacturer
to make a recommendation also for multiple species models
(Live/Dead R© BacLightTM User Manual)3.
Despite this, there has been some discussion about the
reliability of this technique (Hannig et al., 2010; Tawakoli et al.,
2013; Netuschil et al., 2014), mainly due to the fact that not
only red and green bacteria appear in the analysis, but also
orange regions appear with “unknown” interpretation (Berney
et al., 2007). Hannig et al. (2010) considered that live/dead
staining methods were reliable when evaluating antimicrobial
agents activity. However, they continued to ask the question
about “how dead is dead?” due to several stages of vitality which
have been discussed and described in the literature (viable and
culturable, viable but non-culturable, dormant, non-viable and
pre-lytic, and avital dead bacteria). The exact differentiation of
these stages is still one of the greatest challenges in modern
microbiology (Decker, 2001).
Several attempts have been made to compare the Live/Dead R©
BacLightTM with the gold standard -traditional plaque cultures
- (Boulos et al., 1999; Ihalin et al., 2003; Tomás et al., 2009;
Tawakoli et al., 2013). One of these was performed several years
ago by the authors (Tomás et al., 2009) in a study on the in
situ substantivity of the chlorhexidine on the salivary bacteria.
The mean BV obtained was compared with plaque cultures.
A good correlation was observed between both techniques in
the baseline and immediate samples. However, this correlation
3Live/Dead R© BacLightTM User Manual. Available online at: https://tools.
thermofisher.com/content/sfs/manuals/mp07007.pdf (Accessed on September 30,
2017).
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TABLE 1 | Bacterial viability in 2-day PL-biofilm under basal conditions and in the samples collected at 30 s and 1, 3, 5, and 7 h after a single mouthrinse with: sterile
water, traditional essential oils solution, and alcohol-free essential oils solution.
BASAL 30 S 1 H 3 H 5 H 7 H


































































































































BACTERIAL VIABILITY, INTRA-MOUTHWASH ANALYSIS; STATISTICAL SIGNIFICANCE
M-WATER
Layer 1 vs. Layer 2 P < 0.016 P < 0.016 P < 0.016 — P < 0.016 P < 0.016
Layer 1 vs. Layer 3 P < 0.016 P < 0.016 P < 0.016 P < 0.016 P < 0.016 P < 0.016
Layer 2 vs. Layer 3 P < 0.016 P < 0.016 P < 0.016 P < 0.016 P < 0.016 P < 0.016
M-T-EO
Layer 1 vs. Layer 2 P < 0.016 — P < 0.016 P < 0.016 P < 0.016 P < 0.016
Layer 1 vs. Layer 3 P < 0.016 — — P < 0.016 P < 0.016 P < 0.016
Layer 2 vs. Layer 3 P < 0.016 — — P < 0.016 — P < 0.016
M-Af-EO
Layer 1 vs. Layer 2 P < 0.016 P < 0.016 P < 0.016 P < 0.016 P < 0.016 P < 0.016
Layer 1 vs. Layer 3 P < 0.016 — P < 0.016 P < 0.016 P < 0.016 P < 0.016
Layer 2 vs. Layer 3 P < 0.016 — P < 0.016 P < 0.016 P < 0.016 P < 0.016
BACTERIAL VIABILITY, INTER-MOUTHWASH ANALYSIS; STATISTICAL SIGNIFICANCE
M-WATER vs. M-T-EO
Layer 1 vs. Layer 1 P < 0.016 P < 0.016 P < 0.016 P < 0.016 P < 0.016 P < 0.016
Layer 2 vs. Layer 2 — P < 0.016 P < 0.016 P < 0.016 P < 0.016 P < 0.016
Layer 3 vs. Layer 3 — P < 0.016 P < 0.016 P < 0.016 P < 0.016 P < 0.016
M-WATER vs. M-Af-EO
Layer 1 vs. Layer 1 P < 0.016 P < 0.016 P < 0.016 P < 0.016 P < 0.016 P < 0.016
Layer 2 vs. Layer 2 — P < 0.016 P < 0.016 P < 0.016 P < 0.016 P < 0.016
Layer 3 vs. Layer 3 — P < 0.016 P < 0.016 P < 0.016 P < 0.016 P < 0.016
M-T-EO vs. M-Af-EO
Layer 1 vs. Layer 1 — — — — — —
Layer 2 vs. Layer 2 — — — — — —
Layer 3 vs. Layer 3 — — — — — —
Differences between the three biofilm layers, as well as intra-mouthrinse and inter-mouthrinse comparisons. M-WATER, A single, 30-s mouthwash with 20mL of sterile water; M-T-EO,
A single, 30-s mouthwash with 20mL of a traditional essential oils solution; M-Af-EO, A single, 30-s mouthwash with 20mL of an alcohol-free essential oils solution. —, no statistical
significance.
Frontiers in Microbiology | www.frontiersin.org 9 November 2017 | Volume 8 | Article 2162
Quintas et al. Essential Oils Activity on Biofilm
TABLE 2 | Bacterial viability, thickness, and covering grade of the PL-biofilm after 4 days of applying the three different rising protocols.
Bacterial viability (%) Thickness (µm) Covering grade (%)
BACTERIAL VIABILITY, THICKNESS, AND COVERING GRADE OF THE 4-DAY PL-BIOFILM MEAN ± STANDARD DEVIATION; MEDIAN (INTERQUARTILE
RANGE)
4D-WATER 51.35 ± 5.38 22.76 ± 6.21 73.92 ± 17.49
50.70 (6.69) 24.24 (5.72) 76.23 (15.59)
4D-T-EO 26.27 ± 14.61* 9.92 ± 2.87* 46.61 ± 19.12*
22.68 (15.87)* 9.66 (3.80)* 45.49 (24.51)*
4D-Af-EO 31.08 ± 16.52* 7.90 ± 2.91*§ 33.36 ± 12.01*§
29.66 (14.61) 7.23 (2.29)*§ 32.97 (14.92)*§
4D-WATER, Period of 4 days while the volunteer performs two daily mouthwashes with 20mL of sterile water; 4D-T-EO, Period of 4 days while the volunteer performs two daily
mouthwashes with 20mL of a traditional essential oils solution; 4D-Af-EO, Period of 4 days while the volunteer performs two daily mouthwashes with 20mL of an alcohol-free essential
oils solution. *Statistically significant differences in regard with the 4D-WATER, P < 0.016. §Statistically significant differences in regard with the 4D-T-EO, P < 0.016.
was lost as time passed, since plaque cultures could not detect
the BV rise produced in the following samples. This led to an
overestimation of the in situ effect of the antiseptic on cultivated
bacteria, as previously demonstrated by other authors (Boulos
et al., 1999; Ihalin et al., 2003). One of the reasons for this lack of
correlation could be the fact that only 50% of the oral microbiota
is culturable (Aas et al., 2005), which emphasizes the necessity of
using viability assays (Tawakoli et al., 2013; Quintas et al., 2015b).
On the other hand, the BacLightTM system has been proposed
as a reliable alternative when assessing BV in natural dental
biofilm (Tawakoli et al., 2013). Furthermore, the fact of
performing multiple measurements, as previously described, in
every volunteer in each of the tests, being at the same time,
a crossover study, considerably reduce the potential bias that
could exist by the determination of the BV by this technique; in
addition, it allows a better reproducibility in this type of studies.
Given that all microbiological techniques have their
disadvantages, and although the presented results are coherent
with the clinical reality, the authors recognize the convenience
of contrasting and complementing the data obtained with
BacLightTM fluorescence solution with other molecular or
bacteriological techniques or even with other fluorescent
dyes.
Influence of a Single Mouthwash of T-EO
and Af-EO on the Thickness of the
PL-Biofilm
In the literature, very variable thickness measures have been
identified in a non-disturbed 48 h-biofilm (Netuschil et al., 1998;
Zaura-Arite et al., 2001; Arweiler et al., 2004; Auschill et al., 2004,
2005; Al-Ahmad et al., 2007; Dong et al., 2010; Gu et al., 2012;
García-Caballero et al., 2013; Prada-López et al., 2015a,b; Quintas
et al., 2015b). This is due to the variability in the plaque formation
of the different volunteers (Zaura-Arite et al., 2001) or, in some
cases, the way the thickness is measured by the authors (Prada-
López et al., 2015b). In the present study, the 48 h-biofilm had a
thickness of 20–22µm, which agrees with those found in studies
on the PL-biofilm formed in situ (21–27µm; Dong et al., 2010;
García-Caballero et al., 2013; Prada-López et al., 2015b; Quintas
et al., 2015b). After a single mouthwash, no reduction in the PL-
biofilm thickness was found with any of the EO solutions. This
finding is consistent with the previous literature regarding EO
(Dong et al., 2010; Quintas et al., 2015b); it was only in the case of
the 0.2% chlorhexidine solution that some slight reductions could
be detected (García-Caballero et al., 2013).
Influence of a Single Mouthwash of T-EO
and Af-EO on the Bacterial Viability of the
PL-Biofilm
In the present series, both EO solutions achieved excellent
antibacterial activity, with BV reductions between 57 and 67%
and reaching levels of around 5% at 30 s. After the high
immediate antibacterial effect that both formulations had, the
BV started its slow recovery, albeit more gradually in the case
of the Af-EO solution. In any case, both EO mouthwashes were
able to maintain the BV under basal levels until 7 h after a single
application, maintaining at that moment a 45–50% difference in
BV compared to the baseline values.
There are no results in relation to the immediate effect or
substantivity for the Af-EO rinse, but some research has been
conducted in this field on T-EO solutions. In a previous study
of our research group, in which we compared the antibacterial
activity of T-EO with those of 0.2% chlorhexidine, we detected
that the T-EO antiseptic had an even greater antibacterial effect
than the chlorhexidine (Quintas et al., 2015b). In fact, the T-
EO rinse had an immediate BV near to zero (it was around 1%)
compared to 5% for the 0.2% chlorhexidine. In that study, the
T-EO rinse also maintained the BV under baseline levels up to
7 h post-rinsing (Quintas et al., 2015b). In contrast, other studies
found that T-EO solutions were not as effective as described in
this paper. In this sense, Gosau et al. (2010) found that the BV
after a single application of T-EO was around 20%. However, a
methodological comment should be made at this point. Gosau
et al. used a similar in vivo model to the one used in our paper,
but the two studies differ in how the T-EO rinses were applied
(Gosau et al., 2010). In our experiment, the T-EO were applied
as an active mouthwash by the volunteers; in Gosau et al.’s
study the disks were removed from the oral cavity and immersed
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FIGURE 4 | Representative images of the PL-biofilm thickness after 4 days of
continuous use of: (A) Sterile water (4D-WATER), (B) Traditional essential oils
(4D-T-EO), and (C) Alcohol-free essential oils (4D-Af-EO).
passively in a T-EO solution. This procedure has been found
to not be as effective as an active mouthwash at reducing the
BV of the PL-biofilm formed in situ, particularly in its deepest
regions (Prada-López et al., 2015a). Furthermore, differences
have been found between not only T-EO rinses but also 0.2%
chlorhexidine solutions (Prada-López et al., 2015a). For these
reasons, the application methodology of an oral antiseptic should
be taken into account when considering the in situ antibacterial
activity, since oral hydrodynamic forces play an important role
in the activation and penetration of the antiseptic in the complex
bacterial network that an oral biofilm constitutes (Prada-López
et al., 2015a).
The PL-biofilm obtained after 2 days followed a previously
described pattern (Dong et al., 2010; Prada-López et al., 2015b;
Quintas et al., 2015b), with a BV that was significantly lower
in the deeper than the outer layers. This pattern was also
followed after the different mouthwashes were applied, except in
the immediate samples. Thereafter, the BV gradually increased
mainly in the outer layers of the biofilm. These results are also
consistent with previous research in the field (García-Caballero
et al., 2013; Quintas et al., 2015b).
Influence of a 4-Day Protocol of T-EO and
Af-EO Mouthwashes on the Thickness and
Covering Grade of the PL-Biofilm
Despite the multitude of studies conducted on a 4-day model of
plaque regrowth (Addy et al., 1990; Jenkins et al., 1991; Moran
et al., 1997; Rosin et al., 2002; Pizzo et al., 2008, 2013; Ulkur
et al., 2013; Prada-López et al., 2015b; Quintas et al., 2015a), very
few of them have analyzed the plaque without distortion (Prada-
López et al., 2015b; Quintas et al., 2015a). This is not a minor
issue, as it has been proved that the three-dimensional structure
of the oral biofilm plays a very important role in the biofilm’s
defense against external agents and is crucial in its development
(Wood et al., 2000). In addition, distorting the original structure
of the oral biofilm does not permit the measurement of the dental
plaque thickness or its BV by layers when it comes to assessing the
penetration power of the antiseptic (Prada-López et al., 2015b).
After 4 days of dental plaque accumulation with the
performance of daily mouthwashes with sterile water, the
obtained thickness (22.8µm) was consistent with that described
in previous publications using the same methodological design
(Quintas et al., 2015a; which achieved an oral biofilm thickness
of 23.43µm). In another study carried out by the Arweiler’s
group (Arweiler et al., 2008) obtained a biofilm of 25.33µm after
immersing the oral biofilm samples in saline twice daily for 5
days. These thicknesses are in line with those obtained by other
experiments assessing periods of 3-5 days of evolution (Netuschil
et al., 1998; Auschill et al., 2001; Al-Ahmad et al., 2007) when
studying the oral biofilm, and varied between 7 and 45µm.
The two EO mouthwashes were effective at reducing the
thickness of the biofilm formed after 4 days compared to the
negative control. In fact, the mean thickness measured for the Af-
EO solution was almost three times less thick than that obtained
with the sterile water (7.9 vs. 22.8µm); in case of the T-EO
solution, the mean thickness was less than half that for the sterile
water (9.9 vs. 22.8µm). These results are in accordance with
previous investigations on EO and other antiseptics (Jentsch
et al., 2002, 2013; Quintas et al., 2015a). In an earlier study,
researchers found a thickness of 10µm after 4 days of the
continuous use of EO (Quintas et al., 2015a). Jentsch et al. (2013),
using a scanning electron microscope, obtained a thickness
of 10.5µm after 3 days of the daily use of T-EO. For other
antiseptics, the findings vary depending on the mouthwash and
the duration of the experiment. For 0.2% chlorhexidine, the
results ranged from 6.5µm after 4 days (Quintas et al., 2015a)
to 11.91µm after 5 days (Arweiler et al., 2008). When a lower
concentration was applied (0.12% chlorhexidine), the thickness
rose to 14.02µm after 3 days (Jentsch et al., 2002); in this
same study, the antiplaque effect of the stannous fluoride was
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FIGURE 5 | Representative images and graphics of the disks covering grade by the PL- biofilm after 4 days of continuous use of sterile water (4D-WATER), traditional
essential oils (4D-T-EO), and alcohol-free essential oils (4D-Af-EO).
TABLE 3 | Bacterial viability of the PL-biofilm after 4 days of applying the three different rising protocols, differentiating by layers.
LAYER 1 (outer layer) LAYER 2 (middle layer) LAYER 3 (inner layer)
BACTERIAL VIABILITY (%) OF THE 4-DAY PL-BIOFILM BY LAYERS MEAN ± STANDARD DEVIATION; MEDIAN (INTERQUARTILE RANGE)
4D-WATER 82.47 ± 7.58-I 51.76 ± 13.53-I 19.83 ± 12.60-I
81.00 (11.38)-I 45.30 (16.82)-I 17.42 (8.19)-I
4D-T-EO 40.10 ± 17.31*-I 24.32 ± 16.16*-I 14.40 ± 14.34-I
39.52 (21.20)*-I 21.17 (15.98)*-I 11.00 (17.00)-I
4D-Af-EO 39.81 ± 19.09*-I 30.73 ± 17.06*-I 22.71 ± 17.05-I
35.14 (22.21)*-I 29.26 (14.16)*-I 17.37 (12.04)-I
4D-WATER, Period of 4 days while the volunteer performs two daily mouthwashes with 20mL of sterile water; 4D-T-EO, Period of 4 days while the volunteer performs two daily
mouthwashes with 20mL of a traditional essential oils solution; 4D-Af-EO, Period of 4 days while the volunteer performs two daily mouthwashes with 20mL of an alcohol-free essential
oils solution. *Statistically significant differences in regard with the 4D-WATER between the same layers (inter-mouthwash and intra-layer comparisons), P< 0.016. -IStatistically significant
differences between the different layers of the same mouthwash (intra-mouthwash and inter-layer comparisons), P < 0.016.
evaluated, obtaining a thickness of 11.9µm after the same period
of time.
After comparing the thickness obtained for both EO
formulations, there was an unexpected result: the Af-EO rinse
was more effective than the T-EO rinse at reducing the biofilm’s
thickness. This finding will be discussed further, along with the
CG results.
The CG can be predictive of the adaptation of microorganisms
to environmental influences (Al-Ahmad et al., 2008). For this
reason, this parameter is crucial and is directly related to the
antiplaque effect of an antiseptic agent. Despite this, it has
traditionally been forgotten in microbiological studies. In fact, to
the best of the author’s knowledge, there is only one published
article on this issue involving a 4-day PL-biofilm in situ (Quintas
et al., 2015a). Our results are accordance with this paper, as
the CG for the negative control was almost the same (around
73–75%) and it was slightly better for the T-EO rinse (47 vs.
54%). EO solutions were, however, less effective than the 0.2%
chlorhexidine, which had a CG of 20% in the same time period.
No results were found for the Af-EO rinse, which in the present
series had a CG of 33% and were more effective than the T-EO
solution at reducing this microscopic parameter.
Influence of a 4-Day Protocol of T-EO and
Af-EO Mouthwashes on the Bacterial
Viability of the PL-Biofilm
After 4 days of growthwith any disturbing agent other than sterile
water, the oral biofilm had a BV of 51%. This observation is
consistent with previous research in the field, with results that
are slightly over 50% for the BV (Arweiler et al., 2008; Quintas
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et al., 2015a). In addition, the lowest viability was in the deepest
layer, which had BV levels that did not differ toomuch from those
detected after the application of the EO mouthwashes.
This phenomenon has been repeatedly described in the
literature, since bacteria located in the lower strata of the biofilm
receive fewer nutrients, and so acquire an inactive metabolic
state (Netuschil et al., 1998; Pratten et al., 1998). Furthermore,
it is deeply related to the greater thickness and density of the
biofilm, which makes the correct flow of nutrients and oxygen
more difficult to achieve in the deeper layers (Wood et al., 2002).
In the present series, the BV of the 4-day PL-biofilm was
reduced by the T-EO and Af-EO solutions (49 and 40%,
respectively compared to the negative control). No other studies
have been found in relation to the Af-EO, but T-EO rinses have
previously been shown to have a greater antiplaque effect in
terms of reducing BV of PL-biofilm after 4 days of use, achieving
reduction levels close to those of 0.2% chlorhexidine (74 vs. 77%;
Quintas et al., 2015a). In another in vivo study, Arweiler et al.
(2008) found that 0.2% chlorhexidine reduced BV of biofilm by
62% after 5 days of use compared to the negative control.
Clinical Studies on the Antiplaque Effect of
EO Formulations
In the present study, a T-EO rinse containing alcohol and an
Af-EO solution were used, enabling the effects of one to be
compared with those of the other. This is the first study in
the literature to compare the antiplaque effect of T-EO and
Af-EO solutions in an in situ model of non-destructured PL-
biofilm grown after 4 days, with the thickness, CG and BV
analyzed. However, some studies in the literature have evaluated
the effects of both antiseptics at 3–4 days (Marchetti et al.,
2011, 2017a,b; Pizzo et al., 2013; Ulkur et al., 2013). In these
studies, the authors compare the antiplaque effect assessed by
clinical parameters (Marchetti et al., 2011, 2017a,b; Pizzo et al.,
2013) or the efficacy of both solutions at reducing S. mutans
levels (Ulkur et al., 2013). Marchetti et al. (2011) used a 3-
day plaque growth model in which the area occupied by plaque
was evaluated after performing two daily rinses for 1min with
20mL of different EO solutions. T-EO rinses were shown to
be more effective at reducing clinical indexes of dental plaque
after 3 days (2.18 vs. 2.46). This same group also performed
subsequently a similar study (Marchetti et al., 2017a), in which
the same Af-EO formulation obtained a similar result (plaque
index = 2.45) that was less effective than 0.2% chlorhexidine
(plaque index = 1.41). Pizzo et al. (2013) assessed the antiplaque
effect of both EO solutions using a plaque index in a 4-day
experiment. Equally, they found that the Af-EO rinses were
not effective at reducing plaque levels (no differences with
regard to the negative control). These macroscopic results do
not agree with the microscopic results obtained in the present
series, as the thickness and the CG percentage of the PL-biofilm
were statistically lower for the Af-EO mouthwash with respect
to the T-EO mouthwash. These differences can be explained
by the fact that the previous three studies used an alcohol-
free formulation (Curasept Daycare, Curaden International AG,
Kriens, Switzerland) and another with alcohol (Listerine R©,
Johnson & Johnson, S. Palomba-Pomezia, Italy) from different
manufacturers. In our opinion, this methodological aspect can
significantly influence the findings obtained. In fact, recently,
another study from Marchetti’s group (Marchetti et al., 2017b)
compared the alcohol-free and the traditional formulations with
ethanol from the same manufacturer (Johnson & Johnson).
They found that both solutions were effective compared to the
negative control (plaque index = 1.7 vs. 2.3), which confirms
the importance of comparing formulations from the same
manufacturer. In our case, we used two products from the same
manufacturer (Johnson & Johnson, Madrid), which is better for
comparison purposes, since the active principles may not be the
only ones responsible for the antiplaque effect.
Antiplaque Effect of Af-EO: The Importance
of the “Inactive” Ingredients in the Formula
In the formulation of oral antiseptics, the active principles play a
significant role in the activity against the oral biofilm. However,
in the case of chlorhexidine, for example, it has been shown
that different formulations with the same concentration of active
ingredients produce different results in terms of antimicrobial
efficacy (Herrera et al., 2003). The differences in the present series
to other findings in the literature may relate to the presence of
sodium lauryl sulfate, which is used to dissolve EO (Vlachojannis
et al., 2015).
The better microscopic results in the present series of the
Af-EO mouthwash in relation to the CG and thickness can
be explained by a dual theory. The composition of the two
rinses differs, apart from the ethanol, in that sodium lauryl
sulfate is present in Listerine R© ZeroTM, but not in MentolTM.
This component has been shown to be effective at reducing
BV (Jenkins et al., 1991; Petersen et al., 2006; Ledder et al.,
2010) and plaque formation (Waaler et al., 1993; Robinson et al.,
2006). Its antibacterial effect may be due to the formation of
pores in bacterial membranes, which could increase membrane
fluidity, reduce phospholipid chains in the membrane, increase
the rotation movement of lipid molecules, and change the lateral
distribution of proteins and membrane lipids (Petersen et al.,
2006). Its effect on dental plaque may be due to a loss of high-
density particles present in the cell matrix. Robinson et al. (2006)
explained that the removal of structural material by this detergent
essentially affects high-density proteins and molecules. This fact
could improve the penetrability of the antiseptic, resulting in a
greater antiplaque effect. The existence of an inhibitory effect
of sodium lauryl sulfate on glucosyl and fructosyl transferases
has been identified. These are the enzymes responsible for the
synthesis of exopolysaccharides in S. mutans (Petersen et al.,
2006). This component has been shown to be especially effective
against S. mutans, as it also reduces lactate formation by 33%
(Petersen et al., 2006). In fact, Ulkur et al. (2013) found that
both formulations tested in our study had the same effect against
these bacteria in a 4-day oral biofilm model. In the present series,
the bactericidal effects of the sodium lauryl sulfate may not have
manifested, because the Minimum Inhibitory concentration has
not been sufficient to affect the BV, although it may have acted on
the metabolic level of the bacteria.
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As for the other differentiating element, namely ethanol, its
effects on the biofilm were studied extensively in the 1990s.
Accordingly, the bacteria present in biofilms have adapted
physiologically and become more resistant to stress, including
that induced by antimicrobial agents (Anwar et al., 1992;
Sissons et al., 1996). A possible mechanism by which alcohol
resistance above concentrations over 4% could occur is the
induction of an adaptive stress response by bacteria (Boutibonnes
et al., 1991; Piper et al., 1994; Sissons et al., 1996). In fact,
in previous studies, an increase in plaque growth in vivo was
described in a 4-day model after rinsing twice a day with 50%
ethanol (Gjermo et al., 1970). Sissons et al. (1996) reported that
alcohol concentrations between 20 and 30% initially produced
a rapid inactivation of the bacteria present in the biofilm, but
quickly lost its activity and a large resistant population remained
unchanged.
In the same sense, long-term studies (Gordon et al., 1985)
appear in the literature comparing the use of EO containing
ethanol to a negative control of water and its own dissolution
vehicle (alcohol at 26.9% and the rest of the excipients).While EO
had a significant antiplaque effect after 9 months of continuous
use, the dissolution vehicle produced a 7.3% increase in plaque
levels after this period of application. These results reinforce the
theory that the ethanol per se could cause an increase in plaque
formation.
CONCLUSIONS
In a 2-day in situ oral biofilm model, after a single mouthwash,
both essential oils formulations had very high immediate
antibacterial activity and a substantivity which lasted for at least
7 h after application. In a 4-day in situ oral biofilm model, both
essential oils formulations demonstrated a very good antiplaque
effect. Although, both essential oils solutions performed well at
reducing bacterial viability, the alcohol-free formula performed
better at reducing the biofilm thickness and covering grade.
Consequently, the alcohol-free essential oils solution represents
a reliable option as antibacterial and antiplaque agent for the
control of oral biofilm.
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